EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Risanamento (RN) fair value: what the stock is really worth

We calculate from audited financials what Risanamento is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.

Valuation from Jun 25, 2026. With the latest figures (losses, negative cash flow), a fair value can no longer be calculated.
  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Real Estate · IT · ISIN IT0001402269

R Thin data Jun 25, 2026

Risanamento

RN · MI

Weakest SetupStrongly overvalued and low quality.

!Fair value €0.0100 · Strongly overvalued (−78%)
!Quality 31/100
!Weak Growth (revenue 5y −59.8 %/yr)
!Loss-making · -73.8% net margin (TTM)
!Low debt · negative free cash flow
!Trails peers (2/10)
!Narrow moat 6/100
!Evidence only low, so the estimate is less certain
Watch Risanamento for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

€0.1600 €0.0137 Fair Value €0.0100 Jul 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jun 25, 2026.

How to read this chart

60‑month range €0.0137 – €0.1600 · the €0.0447 price screens above the €0.0100 fair value. Dashed = 300-day average. As of Jun 25, 2026.

Follow Risanamento in your weekly email

Every Wednesday you see whether Risanamento is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Risanamento SpA is a property and development company in Italy. The company focuses on redevelopment and development activities, including environmental remediation and public infrastructure works in the metropolitan area of Milan Santa Giulia, located in the south-east of Milan.

Show more

Risanamento SpA is a property and development company in Italy. The company focuses on redevelopment and development activities, including environmental remediation and public infrastructure works in the metropolitan area of Milan Santa Giulia, located in the south-east of Milan. It also has redevelopment projects in Via Grosio in north-west Milan and Torri di Quartesolo in the province of Vicenza. Risanamento SpA is based in Milan, Italy.

Stock analysis

Risanamento (RN) currently trades at €0.0447, while our model-based Fair Value estimate is €0.0100, implying the stock looks roughly 347.0% overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 2 models at a data quality of 91/100, which puts the evidence level at low.

Quality & growth

The Quality Score stands at 31/100 (below-average quality), in the Real Estate sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

Risanamento reported revenue of €134K in FY2024 versus €359K in FY2020, a compound −21.8%/yr. Reported net income was −€47.5M in FY2024.

Key figures

Market cap €80.5M · P/S ratio 1.79 · EPS (TTM) €−0.0100 · Net margin −73.8% · Return on equity −212% · Return on assets (EBIT) −7.4% · Operating margin −33.6% · Revenue growth (YoY) +369%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (low confidence).

What moves the price

The share trades about 8% below its 52-week high and 226% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Real Estate peers we cover trades at −37% fair-value upside, at −78%, RN screens richer than that median.

Notify me when RN reaches fair value

Put RN on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 31/100

Of which business quality 32 · Market factors (momentum, volatility) 84

Profitability 0
Margins and returns on capital today
Quality Growth 40
Are margins and returns improving?
Cashflow 3
Earnings quality: real cash, not paper profit
Fin. Strength 39
Balance sheet, leverage, solvency risk
Investment 67
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 100
Price trend over the last 3–12 months (market factor)
52W Momentum 95
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−100.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−39.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−59.8%
Revenue growth 24 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−43.7%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−116.9% (2019) → −34,923.9% (2024)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2024 is a loss year, no rate is defined from a loss
not computed

RN screens 347% overvalued. Compare with Vingroup Joint Stock Company →

Compare Risanamento with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Real Estate Services · 547 stocks

Beats the industry median on 1/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 33 · Bottom 25%
Fair Value upside −78% · Bottom 25%
Profitability
Return on assets −11% · Bottom 25%
Net margin (TTM) −74% · Bottom 25%
Operating margin (TTM) −34% · Bottom 25%
Growth and dividend
Revenue growth 369% · Top 25%

Valuation Multiplesvs Real Estate Services median · lower = cheaper

P/B 17.73× · Priciest 25%
P/S (TTM) 2.61× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 37
FUTURE (revenue growth)100 · sector 12
PAST (return on equity)0 · sector 16
HEALTH (low debt)100 · sector 83
DIVIDEND (yield)0 · sector 65

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Real Estate Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Vingroup Joint Stock Company VIC 236,000 VND 25,731 VND −89%
CBRE Group CBRE $141.05 $89.43 −37%
Vonovia SE VNA €17.09 €36.67 +115%
Cellnex Telecom, S.A CLNX €25.33 €23.78 −6%
KE Holdings 2423 HK$42.78 HK$17.18 −60%
Jones Lang LaSalle Incorporated JLL $324.06 $530.17 +64%
Swire Properties Limited 1972 HK$24.40 HK$13.50 −45%
CoStar Group CSGP $28.77 $6.17 −79%
China Resources Mixc Lifestyle Services Limited 1209 HK$37.44 HK$56.43 +51%
CapitaLand Investment Limited 9CI 2.62 SGD 0.5000 SGD −81%

Explore undervalued stocks

More undervalued Real Estate stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Risanamento · Fair Value
€0.0100 −347%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Risanamento Fair Value". https://www.fairvalue-calculator.com/stock/RN

Frequently asked questions

Is Risanamento (RN) overvalued or undervalued?
As of Jun 25, 2026, our model estimates a fair value of €0.0100 versus a price of €0.0447, about −78% upside (overvalued).
What is the fair value of RN?
Our model-based fair value for Risanamento is €0.0100 (as of Jun 25, 2026), built from audited fundamentals. The current price: €0.0447.
What is the quality score of RN?
Risanamento has a Quality Score of 31/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Risanamento (RN)?
Our model-based price target is the fair value of €0.0100 (as of Jun 25, 2026) from 2 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Risanamento stock forecast for 2026?
Our models put fair value at €0.0100, about −78% upside versus a price of €0.0447 (overvalued). The calculation is refreshed regularly with new filings.
What is the intrinsic value of Risanamento (RN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Risanamento it is €0.0100 per share (as of Jun 25, 2026), against a price of €0.0447. It is the blended result of 2 valuation models (cash flow, earnings, asset, dividend).
Is Risanamento stock overvalued or undervalued in 2026?
As of Jun 25, 2026, RN trades above its calculated fair value: price €0.0447, fair value €0.0100, a gap of about −78% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of RN?
No. The price is what the market pays today (€0.0447); the fair value is what the company's own numbers justify (€0.0100). For Risanamento the two are €0.0347 per share apart. That gap is exactly why we show both numbers side by side.
How much is Risanamento worth?
The market values Risanamento at about €80.5M (market capitalisation, as of Jun 25, 2026). Per share that is €0.0447; our models calculate a fair value of €0.0100 per share.
How solid is the balance sheet of Risanamento (RN)?
Balance-sheet figures for Risanamento (as of Jun 25, 2026): return on equity −212.3%. They feed the Quality Score of 31/100, which measures business quality independently of the share price.
How far is RN from its 52-week high?
Risanamento trades at €0.0447, about 8% below its 52-week high of €0.0485 and 226% above the low of €0.0137 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of €0.0100 is for.
Which stocks are comparable to Risanamento?
From the same area (Real Estate) we also value Vingroup Joint Stock Company, CBRE Group, Vonovia SE, Cellnex Telecom, S.A, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Risanamento stock attractive at the current price?
The data as of Jun 25, 2026: price €0.0447, calculated fair value €0.0100 (−78%), Quality Score 31/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of RN calculated?
We run Risanamento through 2 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €0.0100, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Risanamento itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Risanamento (RN)?
The closing price on Sep 24, 2026 was €0.0447. Our model-based fair value is €0.0100, about −78% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Risanamento right now?
Weak quality (31/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.

Key figures of Risanamento

How large is the market capitalisation of Risanamento (RN)?
The market capitalisation of Risanamento is €80.5M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Risanamento (RN)?
The price-to-sales ratio of Risanamento is 1.79 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Risanamento (RN)?
Earnings per share at Risanamento are €−0.0100. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Risanamento (RN)?
The net margin of Risanamento is −73.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Risanamento (RN)?
The return on equity (ROE) of Risanamento is −212% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Risanamento (RN)?
On an EBIT basis the return on assets of Risanamento is −7.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Risanamento (RN)?
The operating margin of Risanamento is −33.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Risanamento (RN)?
Revenue at Risanamento is growing +369% versus a year earlier (3y avg −39.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Risanamento (RN) generate?
The free cash flow of Risanamento is −€30.8M (fiscal year 2024). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Risanamento (RN) hold?
Risanamento holds more cash than debt, €50.2M net (fiscal year 2023). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Risanamento in the live analysis

One click puts Risanamento on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.